ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $100,996,000 | -29.8% | 2,498,826 | -0.1% | 0.01% | -20.0% |
| Q2 2015 | $143,929,000 | -28.7% | 2,500,831 | -21.1% | 0.02% | -28.6% |
| Q1 2015 | $201,885,000 | +26.7% | 3,170,831 | +22.9% | 0.02% | +31.2% |
| Q4 2014 | $159,317,000 | +53.3% | 2,580,447 | -3.6% | 0.02% | +45.5% |
| Q3 2014 | $103,933,000 | +25.3% | 2,676,552 | +11.2% | 0.01% | +22.2% |
| Q2 2014 | $82,941,000 | -20.3% | 2,407,618 | -0.0% | 0.01% | -25.0% |
| Q1 2014 | $104,042,000 | -21.1% | 2,407,833 | -59.1% | 0.01% | +50.0% |
| Q4 2013 | $131,922,000 | +32.8% | 5,886,568 | +122.4% | 0.01% | -33.3% |
| Q3 2013 | $99,345,000 | +36.4% | 2,646,261 | -2.4% | 0.01% | +33.3% |
| Q2 2013 | $72,830,000 | – | 2,710,419 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |